Abstract
Rhabdomyosarcoma (RMS) is a tumour that may arise in any part of the body where striated muscle is found. It is the most common soft-tissue tumour in childhood and represents 8% of all malignant diseases in children under 15 years [1]. It is clearly distinct from other soft-tissue sarcomas (discussed in Chap. 26, this volume). The incidence of RMS shows two peaks: an early one between ages 1 and 7 years and a second one during adolescence (Fig. 1) [2]. The median age at diagnosis is 5 years in studies carried out by the International Society of Paediatric Oncology (SIOP). There is a higher incidence among males (sex ratio 1.7).
Preview
Unable to display preview. Download preview PDF.
References
Young JL, Miller RW (1975) Incidence of malignant tumors in United States children. J Pediatr 86: 254–258
Miller RW, Dalager NA (1974) US childhood cancer deaths by cell type 1960–68. J Pediatr 85: 664–668
Willis RA (1962) The borderland of embryology and pathology, 2nd edn. Butterworths, London
Ruymann FR, Maddux HR, Ragab A, Soule EH, Palmer N, Beltangady M, Gehan EA, Newton A (1988) Congenital anomalies associated with rhabdomyosarcoma: an autopsy study of 115 cases. A report from the Intergroup Rhabdomyosarcoma Study Committee. Med Pediatr Oncol 16: 33–39
McKeen EA, Bodurtha J, Meadows AT, Douglass EC, Mulvihill JJ (1978) Rhabdomyosarcoma complicating multiple neurofibromatosis. J Pediatr 93: 992–993
Li FP, Fraumeni JF (1969) Soft tissue sarcomas, breast cancer and other neoplasms: a familial syndrome. Ann Intern Med 71: 747
Li FP, Fraumeni JF Jr, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA, Miller RW (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48: 5358–5362
Malkin D, Li FP, Strong LC, Fraumeni JF, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, Friend SH (1990) Germ line p. 53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 250: 1233–1238
Birch JM, Hartley AL, Blair V, Kelsey AM, Harris M, Teare MD, Morris-Jones PM (1990) Identification of factors associated with high-risk in the mothers of children with soft tissue sarcoma. J Clin Oncol 8: 583–590
Caillaud JM, Gérard-Marchant R, Marsden HB, van Unnik AJM, Rodary C, Rey A, Flamant F (1989) Histopathological classification of childhood rhabdomyosarcoma: a report from the International Society of Pediatric Oncology Pathology Panel. Med Pediatr Oncol 17: 391–400
Spiesse B, Hermanek P, Scheibe O, Wagner G (eds) (1982) UICC TNM atlas: illustrated guide to the TNM. pTNM classification of malignant tumors, 2nd edn. Springer, Berlin Heidelberg New York
Donaldson SS, Draper GJ, Flamant F, Gérard- Marchant R, Mouriesse H, Newton WA, Lemerle J (1986) Topography of childhood tumors: pediatric coding system. Pediatr Hemat Oncol 3: 249–258
Donaldson SS (1982) Rhabdomyosarcoma. In: Carter SK, Glatstein E, Livingston RB (eds) Principles of cancer treatment. McGraw-Hill, New York, pp 852–862
Johnson DG (1975) Trends in surgery for childhood rhabdomyosarcomas. Cancer 35: 916–920
Jereb B, Ghavimi F, Exelby P, Zang E (1980) Local control of embryonal rhabdomyosarcoma in children by radiation therapy when combined with chemotherapy. Int J Radiat Oncol Biol Phys 6: 827–833
Malpas JS, Freeman JE, Baxton A (1976) Radiotherapy and adjuvant combination chemotherapy for childhood rhabdomyosarcoma. Br Med J 1: 247–249
Flamant F, Hill C (1984) The improvement in survival associated with combined chemotherapy in childhood rhabdomyosarcoma. A historical comparison of 345 patients treated in the same center. Cancer 53: 2417–2421
Olive D, Flamant F, Zucker JM, Voûte P, Brunat-Mentigny M, Otten J, Dutou L (1984) Paraaortic lymphadenectomy is not necessary in the treatment of localized paratesticular rhabdomyosarcoma. Cancer 54: 1283–1287
Heyn RM, Holland R, Newton WA, Teft M, Breslow N, Hartmann JR (1974) The role of combined chemotherapy in the treatment of rhabdomyosarcoma in children. Cancer 34: 2128–2142
Green DM, Jaffe N (1978) Progress and controversy in the treatment of childhood rhabdomyosarcoma. Cancer Treat Rev 5: 7–27
Donaldson SS (1985) The value of adjuvant chemotherapy in the management of sarcomas in children. Cancer 55: 2184–2197
de Kraker J, Voûte PA (1983) Ifosfamide, mesna and vincristine in pediatric oncology. A phase II study. Cancer Treat Rev 10: 165–166
de Kraker J, Voûte PA (1983) Ifosfamide, vincristine and actinomycin D (IVA) in soft tissue sarcoma, a pilot study. SIOP XVIth annual conference, York, 20–24 September 1983, pp 98–99
Schmitt C, Flamant F, Rodary C, for MMT Group. SIOP-Institut Gustave-Roussy, Ville juif (1989) Efficiency of cisplatin-Adriamycin in combination in children/hood rhabdomyosarcoma. Proc ASCO, 8 March 1989, p 1194
Maurer HM, Moon T, Donaldson M, Fernandez C, Gehan EA, Hammond D, Hays DM, Lawrence W, Newton W, Ragab A, Raney B, Soule EH, Sutow WW and Tefft M (1977) The Intergroup Rhabdomyosarcoma Study: a preliminary report. Cancer 40: 2015–2026
Sutow WW, Sullivan MP, Reid HL, Taylor HG, Griffith KM (1970) Prognosis in childhood rhabdomyosarcoma. Cancer 25: 1384–1390
Tefft M, Fernandez C, Donaldson M, Newton W, Moon TE (1978) Incidence of meningeal involvement by rhabdomyosarcoma of the head and neck in children. Cancer 42: 253–258
Raney RB, Tefft M, Newton WA, Ragab AH, Lawrence W, Gehan EA, Maurer HM (1987) Improved prognosis with intensive treatment of children with cranial soft tissue sarcomas arising in non orbital parameningeal sites. Cancer 59: 147–155
Flamant F, Chassagne D, Cosset JM, Gerbaulet A, Lemerle J (1979) Embryonal rhabdomyosarcoma of the vagina in children. Conservative treatment with curietherapy and chemotherapy. Eur J Cancer 15: 527–532
Heyn R, Ragas A, Raney B, Ruymann F, Tefft M, Lawrence W, Soule E, Maurer HM (1986) Late effects of therapy in orbital rhabdomyosarcoma in children. Cancer 57: 1738–1743
Flamant M, Sarrazin D, Schwaab G (1981) Séquelles tardives des traitements locaux curateurs dans les tumeurs de la sphère ORL chez l’enfant. In: Actualités de carcinologie cervico-faciale, vol 6. Masson, Paris, pp 109–120
Flamant F, Gerbaulet G, Nihoul Fekete C, Valteau-Couanet D, Lemerle J (1990) Long-term sequelae of conservative treatment by surgery, brachytherapy and chemotherapy of vulval and vaginal rhabdomyosarcoma in children. J Clin Oncol 8 /11: 1847–1853
Oberlin O, Flamant F, Tournade MF, Hill C, Lemerle J, Institut Gustave-Roussy, Ville juif (1985) Subsequent cancer in children with rhabdomyosarcoma. SIOP XVIIe meeting, Venice, 30th Sept-4th Oct 1985, p 169
Flamant F, Rodary C, Voûte PA, Otten J (1985) Primary chemotherapy in the treatment of rhabdomyosarcoma in children: trial of the International Society of Pediatric Oncology (SIOP). Preliminary results. Radiother Oncol 3: 187–192
Rodary C, Rey A, Olive D, Flamant F, Quintana E, Brunat-Mentigny M, Otten J, Voûte PA (1988) Prognostic factors in 281 children with non metastatic rhabdomyosarcoma (RMS) at diagnosis. Med Pediatr One 16: 71–77
Rodary C, Gehan EA, Flamant F, Treuner J, Carli M, Auquier A, Maurer H (1991) Prognostic factors in 951 rhabdomyosarcoma in children. A report from the International RMS Workshop. Med Pediatr Oncol 19: 89–95
Rodary C, Flamant F, Treuner J, Carli M, Maurer H for the Workshop Committee (1990). Bladder salvage in 109 non metastatic bladder and/or prostate rhabdomyosarcoma. A report from the International SIOP RMS Workshop. Med Pediatr Onc 18: 5: 405
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Flamant, F., Voûte, P.A., Sommelet, D. (1992). Rhabdomyosarcoma. In: Voûte, P.A., Barrett, A., Lemerle, J. (eds) Cancer in Children. UICC International Union Against Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84722-6_25
Download citation
DOI: https://doi.org/10.1007/978-3-642-84722-6_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84724-0
Online ISBN: 978-3-642-84722-6
eBook Packages: Springer Book Archive